Valuation: Acarix AB

Market Cap 243M 24.44M 21.49M 20.26M 18.49M 34.57M 2.35B 34.84M 94.22M 1.19B 91.74M 89.75M 3.88B P/E 2026 *
-
P/E 2027 * -
Enterprise Value 243M 24.44M 21.49M 20.26M 18.49M 34.57M 2.35B 34.84M 94.22M 1.19B 91.74M 89.75M 3.88B EV / Sales 2026 *
17.4x
EV / Sales 2027 * 7.6x
Free-Float
89.13%
Yield 2026 *
-
Yield 2027 * -
1 week-9.91%
Current month-31.51%
1 month-25.93%
3 months-40.48%
6 months-45.95%
Current year-41.86%
1 week 0.01
Extreme 0.01
0.01
1 month 0.01
Extreme 0.01
0.03
Current year 0.01
Extreme 0.01
0.04
1 year 0.01
Extreme 0.01
0.04
3 years 0.01
Extreme 0.01
0.05
5 years 0.01
Extreme 0.01
0.13
10 years 0.01
Extreme 0.01
2.37
Manager TitleAgeSince
Chief Executive Officer - 2024-01-31
Chief Executive Officer 62 2018-02-22
Director TitleAgeSince
Director/Board Member 61 2019-12-31
Director/Board Member 52 2024-05-13
Director/Board Member - 2024-05-13
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-9.91% - - 24.44M
-1.53%+5.26%+32.84%-17.57% 18.65B
-5.20%-1.26%-40.28%+23.38% 1.85B
-0.12%0.00%-30.46%+23.09% 866M
-0.03%-0.14%+54.39%-2.66% 778M
+0.84%+0.47%-59.79%-85.09% 733M
-0.69%+8.32%-30.46%-46.60% 686M
+1.77%+5.45%-38.77%-51.24% 589M
-0.69%+7.60%+37.83%+87.27% 476M
+4.51%+6.13%-1.37%+8.25% 399M
Average -0.12%+2.21%-8.45%-6.80% 2.78B
Weighted average by Cap. -1.44%+5.29%+19.34%-13.84%

Financials

2026 *2027 *
Net sales 14M 1.41M 1.24M 1.17M 1.06M 1.99M 135M 2.01M 5.43M 68.74M 5.28M 5.17M 224M 32M 3.22M 2.83M 2.67M 2.43M 4.55M 309M 4.59M 12.4M 157M 12.07M 11.81M 511M
Net income -30.8M -3.1M -2.72M -2.57M -2.34M -4.38M -297M -4.41M -11.94M -151M -11.62M -11.37M -492M -15.3M -1.54M -1.35M -1.27M -1.16M -2.18M -148M -2.19M -5.93M -75.12M -5.77M -5.65M -244M
Net Debt - -
Logo Acarix AB
Acarix AB is a Sweden-based provider of diagnostic solutions for coronary artery disease (CAD). The Company’s primary product CADScor System features phonocardiography technique and algorithms. The CADScor System is fixed with a specific patch to the chest of the patient, with the recording head placed at the forth left intercostal space, and the sensor resting on the sternum. Instructions for the procedure are given on the display for the operator and audio cues guide a patient during the two-minute heart sound recording. After recording, the CAD-score is calculated, and presented on the display of the CADScor Sensor, enabling a physicians, nurses and laboratory technicians to make a rule-out diagnosis.
Employees
8
Date Price Change
26-09-25 €0.0100 0.00%
26-09-24 €0.0100 -3.85%
26-09-23 €0.0104 -1.89%
26-09-22 €0.0106 +1.92%
26-09-21 €0.0104 -6.31%

Quarterly revenue - Rate of surprise